JOSHUA MURPHY: Open Payments
NPI 1396339644 · LAMAR, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 35 payments from 12 companies in 2025. Trend: 2023 $367 · 2024 $748 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| Esperion Therapeutics, Inc. | 6 | $101 |
| Abbott Laboratories | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Lilly USA, LLC | 3 | $44 |
| Amgen Inc. | 2 | $37 |
| Corcept Therapeutics | 1 | $25 |
| Novo Nordisk Inc | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: LEQVIO, FARXIGA, NEXLETOL, FREESTYLE LIBRE 3, JARDIANCE, MOUNJARO, Korlym, OTEZLA.
Industry payments across SC — which companies pay providers there.
